Request Trial

Sarah Speight

Key details


Reset all filters
Article Type
Channels & Sectors
Geography
Company
Refine search
Total results: 187

Articles by Sarah Speight

UPC issues first decision on second medical use
Europe
UPC issues first decision on second medical use
Court of First Instance rules on Sanofi v Amgen antibodies dispute | Claims dismissed as “unfounded” and lacking in evidence | All parties ordered to pay costs totalling €45m ($50m).   13 May 2025
UK-India trade deal is ‘a missed opportunity for UK pharma’, says industry body
Europe
UK-India trade deal is ‘a missed opportunity for UK pharma’, says industry body
Industry body says agreement doesn’t address ‘longstanding industry concerns’ about IP | Deal criticised for ‘lack of detail’ on IP, particularly for UK life sciences and general legal sector | £25.5bn deal offers provisions for medical devices | Smith+Nephew hopes deal will help build trade for healthcare.   8 May 2025
'Nothing can stand in the way of our work': Ukraine resumes IP system
Europe
'Nothing can stand in the way of our work': Ukraine resumes IP system
As Ukraine lifts the wartime pause on IP deadlines, the country's lawyers are determined to get back to business as usual—in spite of the ongoing missile attacks and power outages, finds Sarah Speight.   7 May 2025
Americas
Novartis settles with licensee of blood cancer therapy day before trial
The pharma giant and biopharma company Incyte announce settlement of dispute over alleged unpaid royalties | News comes on eve of trial in Manhattan.   6 May 2025
Europe
AstraZeneca to appeal invalidated diabetes patent in generics dispute
EWHC ruling discusses application of EPO case law regarding lack of plausibility and lack of technical contribution | Court had earlier overturned a first-instance decision allowing an injunction against Glenmark’s diabetes generic | AstraZeneca intends to appeal.   29 April 2025
Americas
Why US patent reform is ‘essential’ for US economic prosperity and security
Proposed patent legislation will save US innovation and counter the ‘existential threat’ that China poses to the West, hears Sarah Speight.   29 April 2025
Americas
Medical company sees $452m trade secrets award cut by 87%
US district judge reduces award payable to Insulet by EOFlow to $59.4m l Dispute concerns wearable insulin patch pumps l Injunction remains but with allowance for users to access device temporarily.   29 April 2025
Europe
South Korean firm sues in UK over CRISPR/Cas9 blood disorder drug
Gene editing company ToolGen “seeks fair licensing agreement” for alleged infringement by rival | High-value sickle cell treatment CASGEVY was “born from ToolGen’s proprietary CRISPR RNP tech” says complaint | Potter Clarkson instructed.   22 April 2025
Americas
Novartis and MSN feud intensifies after Fed Circ denies rehearing
Both parties write to district court hours after Court of Appeals denies rehearing | MSN maintains that the Entresto patent should be delisted from the Orange Book | Novartis urges injunction to block generic version of heart treatment before regulatory gap closes.   27 March 2025
Americas
Fed Circ affirms generic’s litigation costs of $12m are tax-deductible
Court of Appeals rules defence costs in Hatch-Waxman cases are deductible as ordinary business expenses | US IRS stands to pay tax rebate to generics manufacturer.   25 March 2025

Not finding what you're looking for, please try resetting your applied search and filters,
or try the full site search.